Radial Access Superior for Coronary Angiography, With Distal Radial and Ulnar Access as Preferred Secondary Options, affirms study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-09-30 03:30 GMT   |   Update On 2024-09-30 06:10 GMT
USA: A network meta-analysis has provided new insights into the procedural outcomes associated with different access points for coronary angiography. The study that compared femoral, radial, distal radial, and ulnar access offers valuable guidance for clinicians in selecting the optimal approach for this critical diagnostic procedure.

The findings, published in Circulation: Cardiovascular Interventions, endorse radial access as the primary choice for coronary angiography, with distal radial or ulnar access recommended over femoral access as a secondary option.

Coronary angiography, a key diagnostic tool for assessing coronary artery disease, traditionally uses femoral access. However, radial access has become increasingly popular due to its lower risk of complications and quicker recovery times. Previous studies have shown that radial artery access for coronary angiography or PCI lowers the risk of death, bleeding, and vascular complications compared to femoral artery access, earning it a class 1 recommendation in clinical practice guidelines. Despite this, alternative upper extremity access options, such as distal radial and ulnar access, are not yet addressed in the guidelines, even though randomized trials support their use.

Advertisement

Against the above background, M Haisum Maqsood, Department of Cardiology, DeBakey Heart and Vascular Center, Methodist Hospital, TX, and colleagues aimed to evaluate procedural outcomes with femoral, radial, distal radial, and ulnar access sites in patients undergoing coronary angiography or PCI.

For this purpose, the researchers searched PubMed, EMBASE, and clinicaltrials.gov databases for randomized clinical trials comparing at least two of the four access sites in patients undergoing PCI or angiography. The primary outcomes analyzed were major bleeding and access site hematoma. An intention-to-treat mixed-treatment comparison meta-analysis was then conducted.

The researchers reported the following findings:

  • From 47 randomized clinical trials that randomized 38 924 patients undergoing coronary angiography or PCI, when compared with femoral access, there was a lower risk of major bleeding with radial access (odds ratio [OR], 0.46) and lower risk of access site hematoma with radial (OR, 0.34), distal radial (OR, 0.33), and ulnar (OR, 0.50) access.
  • Compared with radial access, there was a higher risk of hematoma with ulnar access (OR, 1.48).

"Evidence from randomized trials supports a Class 1 guideline recommendation favoring radial access over femoral access for coronary angiography or PCI. Additionally, when radial access is not feasible, distal radial or ulnar access should be considered as preferred alternatives before resorting to femoral access," the researchers concluded.

Reference:

Maqsood MH, Yong CM, Rao SV, Cohen MG, Pancholy S, Bangalore S. Procedural Outcomes With Femoral, Radial, Distal Radial, and Ulnar Access for Coronary Angiography: A Network Meta-Analysis. Circ Cardiovasc Interv. 2024 Jul 19:e014186. doi: 10.1161/CIRCINTERVENTIONS.124.014186. Epub ahead of print. PMID: 39027936.

Tags:    
Article Source : Circulation: Cardiovascular Interventions

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News